Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Phase 4CompletedNCT00185120

Daiichi Sankyo152 enrolled

Overview

A comparison of 2 different combinations of high blood pressure medications to treat hypertension

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

152

Conditions

Hypertension

Interventions

Olmesartan medoxomilDRUG

HydroclorothiazideDRUG

BenazeprilDRUG

AmlodipineDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Greater than 18 years of age * Patients with high blood pressure Exclusion Criteria: * Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months * History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months * Type 1 diabetes mellitus

Locations (20)

Unnamed facility

Mobile, Alabama, United States

Memorial Research Medical Center

Outcomes

Primary Outcomes

Change in systolic blood pressure from the start of the study

Secondary Outcomes

Change in diastolic blood pressure from the start of the study

Percent of patients who achieve target blood pressure goals

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.